The Medicare GLP-1 Bridge, a temporary program for eligible Medicare beneficiaries living with obesity, began July 1, 2026. The program provides access to certain GLP-1 medications for a $50 monthly copay.^[1] Medicare Open Enrollment begins October 15, 2026 and runs through December 7, 2026.^[2] This enrollment period runs on the same annual schedule each year.^[3] Participants in the Bridge program must have prescription drug coverage through a Part D plan or a Medicare Advantage plan with prescription drug coverage.^[4] Medicare Part D can cover certain GLP-1 medications when prescribed for covered indications including type 2 diabetes, cardiovascular risk reduction, moderate to severe obstructive sleep apnea, or metabolic dysfunction-associated steatohepatitis.^[5] The Obesity Action Coalition has released supporting resources including a Medicare Open Enrollment Checklist and a Bridge Navigator to help users review coverage and eligibility requirements.^[6] Jill Schlesinger warned that health insurance scams are ramping up ahead of the upcoming open enrollment period.^[7]